![小谈2020年全球销量排名前10的药物](https://www.drugtimes.cn/wp-content/themes/justnews/themer/assets/images/lazy.png)
![小谈2020年全球销量排名前10的药物](https://www.drugtimes.cn/wp-content/themes/justnews/themer/assets/images/lazy.png)
Humira(Adalimumab,阿达木单抗)
![小谈2020年全球销量排名前10的药物](https://www.drugtimes.cn/wp-content/themes/justnews/themer/assets/images/lazy.png)
Keytruda(Pembrolizumab,帕博利珠单抗)
![小谈2020年全球销量排名前10的药物](https://www.drugtimes.cn/wp-content/themes/justnews/themer/assets/images/lazy.png)
Revlimid(Lenalidomide 来那度胺)
![小谈2020年全球销量排名前10的药物](https://www.drugtimes.cn/wp-content/themes/justnews/themer/assets/images/lazy.png)
Eliquis(Apixaban,阿哌沙班)
![小谈2020年全球销量排名前10的药物](https://www.drugtimes.cn/wp-content/themes/justnews/themer/assets/images/lazy.png)
Imbruvica(Ibrutinib 伊布替尼)
![小谈2020年全球销量排名前10的药物](https://www.drugtimes.cn/wp-content/themes/justnews/themer/assets/images/lazy.png)
Eylea(Aflibercept 阿柏西普)
![小谈2020年全球销量排名前10的药物](https://www.drugtimes.cn/wp-content/themes/justnews/themer/assets/images/lazy.png)
Stelara(Ustekinumab,乌司奴单抗)
![小谈2020年全球销量排名前10的药物](https://www.drugtimes.cn/wp-content/themes/justnews/themer/assets/images/lazy.png)
Opdivo(Nivolumab,纳武利尤单抗)
![小谈2020年全球销量排名前10的药物](https://www.drugtimes.cn/wp-content/themes/justnews/themer/assets/images/lazy.png)
Biktarvy
![小谈2020年全球销量排名前10的药物](https://www.drugtimes.cn/wp-content/themes/justnews/themer/assets/images/lazy.png)
Xarelto(Rivaroxaban,利伐沙班)
![小谈2020年全球销量排名前10的药物](https://www.drugtimes.cn/wp-content/themes/justnews/themer/assets/images/lazy.png)
![小谈2020年全球销量排名前10的药物](https://www.drugtimes.cn/wp-content/themes/justnews/themer/assets/images/lazy.png)
![小谈2020年全球销量排名前10的药物](https://www.drugtimes.cn/wp-content/themes/justnews/themer/assets/images/lazy.png)
![小谈2020年全球销量排名前10的药物](https://www.drugtimes.cn/wp-content/themes/justnews/themer/assets/images/lazy.png)
推荐阅读
重磅!映恩生物Duality Biologics完成9000万美元B轮融资 中国好CMO | 71位首席医学官!庆祝第17个国际临床试验日 骨关节炎药物简析 | 我们将如何老去——带着疼痛的关节还是矫健的身躯? -
国内PARP抑制剂三足鼎立局面将被打破,百济神州帕米帕利获批在即
![小谈2020年全球销量排名前10的药物](https://www.drugtimes.cn/wp-content/themes/justnews/themer/assets/images/lazy.png)
![小谈2020年全球销量排名前10的药物](https://www.drugtimes.cn/wp-content/themes/justnews/themer/assets/images/lazy.png)
点击这里,欣赏更多精彩内容!
本篇文章来源于微信公众号:药时代
发布者:药时代,转载请首先联系contact@drugtimes.cn获得授权